Faculty Profile

- Dr. Anab Fatima
- Designation
- Associate Professor
- Department
- Pharmaceutics
- Qualification
B Pharm, KU
MPhil KU
PhD, KU
LLB, KU- anab.fatima@duhs.edu.pk
- Office Location
- Ojha Campus, DUHS
Research Interest
Dr Anab Fatima completed her PhD in Pharmaceutics from University of Karachi in 2015 and became an Associate Professor of Pharmaceutics and Clinical Pharmacy at DCOP, DUHS in 2016. She is an HEC approved supervisor as well as a legal consultant (LLB). She has a teaching and research experience of more than 15 years with 26 research publications. She has published her research in various national and international journals and is a brilliant, hard working, devoted teacher, researcher and scholar. She remained the HOD of Pharmacy Practice and Incharge of Succor Drug and Poison Information Center at Hamdard University in 2013-15. Her research interest includes Pharmaceutical Microbiology, Drug interactions, Clinical Pharmacokinetics and Forensic Pharmacy.
Research Publications
1. Pattern of Variable Pharmacokinetic of
Clavulanic Acid from Oral
Formulation of Co-Amoxiclav Alone and with
Antacid in Healthy Subjects. Lat. Am. J.
Pharm. 35 (8): 1799-804 (2016).
1. A REVIEW OF ETHNOBOTANY,
PHYTOCHEMISTRY, ANTIVIRAL AND
CYTOTOXIC / ANTICANCER POTENTIAL OF
MORUS ALBA LINN.
International Journal of Advanced
Research and Review. 1(2), 2016;
84-96.
2. BURDEN OF ORAL CANCERS – A
RETROSPECTIVE APPROACH TO
DETERMINE THE INCIDENCES. Journal of
Disease and Global Health. 4(3): 123-129,
2015.
3. A novel validated RP-HPLC-UV method for
concurrent estimation of Co-amoxiclav in
human plasma. (Journal of International
Research in Medical and Pharmaceutical
Sciences 5(1): 53-59, 2015.
4. Pharmacokinetic evaluation of amoxicillin alone
and simultaneous administration of antacid. Int
J Pharm 2014; 4(4): 102-107
5. Development and validation of RP-HPLC
method for simultaneous determination of
Amoxicillin and Ranitidine in pharmaceutical
formulations.WJPR. 2014; Vol 3, Issue 2,
pp.1662-1671.
6. INCIDENCES, SCREENING AND
MANAGEMENT OF PROSTATE CANCER. Int
J Pharm. 2014; 4(1): 34-41.
7. Staphylococcal resistance against five Groups
of life saving Antibiotics In the Year 2003-2005.
Pak. J. Pharm. Sci., Vol.26, No.6, November
2013, pp.1137-1140.
8. Incidences,screening and pharmacotherapy of
breast cancer.Int J Pharm 2013; 3(4): 705-709.
9. Simultaneous and rapid determination of
amoxicillin and clavulanic acid in
pharmaceutical formulations by reversed-phase
high performance liquid chromatography(RP-
HPLC) method. African Journal of
Pharmaceutical Sciences and Pharmacy 2013;
4:1, pp.58-69.
10. Antimicrobial susceptibility pattern of clinical
isolates from cases of ear infection using
amoxicillin and cefepime.
SpringerPlus 2013, 2:288 doi:10.1186/2193-
1801-2-288
Published: 1 July 2013.
11. Reterospective study of cancer type in different
ethnic groups and gender at Karachi Springer
Plus 19 Mar 2013, 2:118.
12. Antimicrobial susceptibility pattern of clinical
isolates of Pseudomonas aeruginosa isolated
from patients of lower respiratory tract
infections. Springer Plus 18 Dec 2012 1:70.
13. Human papilloma virus induce cancer and
prevention by immunization.
Pak. J. Pharm. Sci., Vol.25, No.4, October
2012, pp.763-772.
14. Prostaglandins and cytokines in Pregnancy and
Labor.
J.Chem.Soc.Pak, Vol.30,No.6,2008.